Drug Shortage Report for ONCASPAR

Last updated on 2024-02-15 History
Report ID 181357
Drug Identification Number 02461900
Brand name ONCASPAR
Common or Proper name Injection de pegaspargase
Company Name SERVIER CANADA INC
Market Status MARKETED
Active Ingredient(s) PEGASPARGASE
Strength(s) 750UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5ml
ATC code L01XX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-02-20
Actual start date
Estimated end date 2024-02-29
Actual end date
Shortage status Actual shortage
Updated date 2024-02-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3224 AVENUE JEAN-BÉRAUD
LAVAL, QUEBEC
CANADA H7T 2S4
Company contact information Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4 Phone : (450) 978-9700

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2024-02-15 French Compare
v18 2024-02-15 English Compare
v17 2024-02-15 French Compare
v16 2024-02-15 English Compare
v15 2023-10-18 French Compare
v14 2023-10-18 English Compare
v13 2023-10-04 French Compare
v12 2023-10-04 English Compare
v11 2023-03-22 French Compare
v10 2023-03-22 English Compare
v9 2023-03-03 French Compare
v8 2023-03-03 English Compare
v7 2023-02-21 English Compare
v6 2023-01-18 French Compare
v5 2023-01-18 English Compare
v4 2023-01-17 French Compare
v3 2023-01-17 English Compare
v2 2023-01-17 French Compare
v1 2023-01-17 English Compare

Showing 1 to 19 of 19